Healthcare Market Research Reports and Trends

The  global  accountable care solutions market  is segmented on the basis of product and service, delivery mode, end users and regions. Based on product and service, the global accountable care solutions market is segmented into healthcare provider solutions, healthcare payer solutions and services.  Healthcare provider solutions accounted for the largest share of the accountable care solutions market covers electronic health/medical records, healthcare analytics, revenue cycle management, patient engagement solutions, population health management solutions, care management solutions, healthcare it integration systems, healthcare information exchange and clinical decision support systems.  Accountable Care Solutions Market Growth Request Free PDF Brochure –  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229274233 Expected to witness the highest growth in the next five years. The growing need to improve the profitability of healthcare operations and government init

The emerging economies such as India, China, and Brazil are expected to provide a wide range of opportunities for players in the market, which is driven by growing healthcare infrastructure, vast population pool, rising demand for quality care, and the increasing healthcare spending. The global  nurse call systems market  is projected to reach USD 2.5 billion by 2024 from USD 1.6 billion in 2019, at a CAGR of 9.2% from 2019 to 2024. Market Dynamics + Drivers + Ease of Communication and Diverse Applications of Nurse Call Systems + Technological Advancements in Nurse Call Systems Request for Free Sample Pages -https://www.marketsandmarkets.com/requestsampleNew.asp?id=230909048 The alarms & communications segment dominated this market in 2019. This segment is expected to have the highest growth as well. Factors attributing for their growth are increased patient safety, essential devices in a healthcare setting, ease of communication between patient and care giver, incr

Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. The  ligation devices market  is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3%. Market Dynamics  + Drivers + Growing Demand for Minimally Invasive Surgery Request for Free Sample Pages -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=22007372 The ligation devices market is segmented into gastrointestinal & abdominal surgeries, gynecological surgeries, cardiovascular surgeries, urological surgeries, and other applications such as wound, ENT, and cosmetic applications. The cardiovascular surgeries segment is anticipated to drive growth in the market at a CAGR of 6.9% over the forecast period. This growth can be attributed to the increase in the incidence of

Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption amongst patients. The global  injection pen market  is expected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017, at a CAGR of 6.0%. Market Dynamics  + Drivers + Growing Prevalence of Chronic Diseases + Increasing Number of Regulatory Approvals + Favorable Reimbursement and Government Support Request for Free Sample Pages -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=42342539 The global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular diseases, rheumatoid arthritis, and migraine). The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the large diabetic population acros

The increase in the prevalence of lung cancer & chronic respiratory disorders globally, combined with the increasing preference for minimally invasive procedures are some of the factors contributing to the growth of this market. However, the associated complication of using these stents and an increase in the availability of alternative treatments might hamper the growth of the airway/lung stents market. The  lung stent market  is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%. Market Dynamics + Drivers  + Rising Prevalence of Lung Cancer and Respiratory Diseases + Increasing Preference for Minimally Invasive Procedures + Continuous Growth in the Healthcare Industry + Increasing Life Expectancy + Rising Healthcare Expenditure + Growing Geriatric Population Request for Free Sample Pages -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890 The market is segmented based on the type, material, product, end user, and region. B

The  growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent. The global  contrast injectors market  is segmented on the basis of application, product, and region. Based on application, the contrast injectors market is segmented into radiology, interventional cardiology, and interventional radiology. The interventional cardiology segment is projected to grow at the highest CAGR during the forecast period. However, the radiology segment is expected to command the largest share of the contrast injector market in 2016. Based on product, the market is categorized into injector systems, consumables, and accessories. The injector systems category is further segmented into CT injector systems, MRI injector sy

The market is witnessing growth due to factors such as increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers, and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. The  respiratory drug delivery market  is segmented based on formulations, canister type, applications, end users, and regions. The formulation segment is further divided into device type and formulation type. The respiratory drug delivery market, by device type, is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The metered dose inhalers segment is expected to account for the largest share of the market by type of delivery by device, in 2016. Factors such as the efficient absorption of drugs through the lungs and negligible side effects (as drugs are exposed only to the lungs) are contributing to the growth of this segment. Download PDF -  https://www.marketsandmarkets.com/

Increasing prevalence of diseases, demand for liquid biopsy, growing demand for blood components, and increasing number of surgeries and accidental cases are the factors driving the growth of the market. Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers. The global  blood collection market  is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5%. Market Dynamics  + Drivers + Increasing Disease Incidence and Growing Number of Accident & Trauma Cases + Emergence of Liquid Biopsy Tests + Rising Demand for Blood Components Request for Free Sample Pages -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=39733117 The blood collection tubes segment to account for the largest share of the market in 2017 The market is broadly segmented into blood collection

A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain diseases could be benefitted by a particular drug through the biomarker assessment. The key factors driving the growth of this market include the increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support the  companion diagnostics market . The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022. The global companion diagnostics market is expected to reach USD 6.51 billion by 2022 from USD 2.17 billion in 2016, at a CAGR of 20.1%. Market Dynamics + Drivers + Improvements in regulatory guidelines + Growing need for targeted therapies + Rising cancer incidence worldwide + Increasing collaborations and partnerships for companion diagnostics test development Increasing collaborations and partnerships for c

Factors such as Rising number of preterm and low-weight births, growing number of NICU admissions, and increased awareness of neonatal and fetal care across developing nations are expected to propel the growth of the market. Fetal (Labor & Delivery) and  Neonatal Care Equipment Market  - (Ultrasound, Doppler, Fetal Monitors (Intrapartum, Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy Devices, Ventilator, MRI, CPAP, Capnograph, Resuscitator)-Global Forecast to 2023 Some of the prominent players in the fetal (labor & delivery) and neonatal care market are GE Healthcare (UK), Philips Healthcare (Netherlands), Drägerwerk AG & Co. KGaA (Germany) Atom Medical Corporation (Japan), Natus Medical Incorporated (US), and Masimo Corporation (U.S.) among others. To know about the assumptions considered for the study download the pdf brochure -  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=412 Analysis of the developments in the fetal and neonatal care equipment

The report " Healthcare Distribution Market  by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) - Global Forecasts to 2024", is projected to grow at a CAGR of 6.5% during the forecast period to reach USD 1,048.4 billion by 2024 from USD 765.4 billion in 2019.  Factors such as the rising incidence of chronic diseases, growing importance of generics, rising adoption of track & trace solutions, and the growth of the medical device industry are expected to drive the growth of this market during the forecast period. Browse 67 market data Tables and 28 Figures spread through 132 Pages and in-depth TOC on "Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) - Global Forecasts to

The report " Track etched Membrane Market  by Product (Membrane Filter, Capsule & Cartridge Filter, Cell Culture Insert), Material (Polycarbonate, Polyimide), Application (Cell Biology, Microbiology, Analytical testing, Automotive), End User - Global Forecast to 2023", The track etched membrane market is expected to reach USD 813.1 million by 2023 from USD 476.0 million in 2018, at a CAGR of 11.3% from 2018 to 2023.  The growth of the pharmaceutical R&D expenditure is expected to be one of the major factors driving the growth of this market during the forecast period. Moreover, the collaborative application of nanotechnology and track etching is expected to increase the adoption of track etched membranes in various applications, such as healthcare, fuel cells, telecommunications, and transportation Browse 85 market data Tables and 37 Figures spread through 140 Pages and in-depth TOC on "Track etched Membrane Market by Product (Membrane Filter, Capsule & Cart

The report  “ EMEA 3D CBCT/Cone Beam CT Systems Market  by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) – Forecast to 2023″ , The EMEA 3D CBCT systems market is expected to reach USD 300.4 Million by 2023 from an estimated USD 194.3 Million in 2018, at a CAGR of 9.0%. With increasing disposable incomes, rising healthcare expenditure, and the availability of health insurance, the willingness to undergo expensive cosmetic procedures in various countries has increased. Moreover, the rising expenditure on treatments for appearance enhancements is driving the demand for dental products in the market. Browse 74 market data Tables and 17 Figures spread through 115 Pages and in-depth TOC on  “EMEA 3D CBCT/Cone Beam CT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT

The report " Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022", The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes. Browse 194 Market Data Tables and 27 Figures spread through 193 Pages and in-depth TOC on "Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022" Get Free PDF - http

The report " HIV Diagnosis Market  by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification), Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021", Report provides a detailed overview of the major drivers, restraints, opportunities, trends, and strategies impacting the HIV diagnosis market along with the estimates and forecasts of the revenue and market share analysis. Browse 72 market data tables and 53 figures spread through 137 pages and in-depth TOC on "HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification), Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021" Get Free PDF -  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66008285 The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 fro